SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...
1don MSN
Promoters and enhancers: Tool catches gene-controlling DNA sequences doing each other's jobs
Researchers at the Weill Institute for Cell and Molecular Biology have uncovered new evidence that two major types of gene-controlling DNA sequences, promoters and enhancers, operate with a shared ...
In gene therapy, promoters act as vital “on/off” switches, dictating whether a therapeutic gene is active and to what extent. While delivery vehicles such as adeno-associated viruses (AAVs) can bring ...
Addressing climate change demands rethinking of established chemical processes on a timescale of years rather than decades as in traditional R&D cycles. In collaboration with BasCat (UniCat BASF ...
Validated, tissue-specific library enables customisable and controllable liver-targeted gene expression with high specificity and minimal off-target activity in muscle tissue SHEFFIELD, England, ...
Validated, tissue-specific library enables customisable and controllable liver-targeted gene expression with high specificity and minimal off-target activity in muscle tissue SynGenSys, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results